Maxx's Top Stock for May 2022 - 7investing 7investing
Stock Tips Mobile Menu Dropdown Icon

Maxx’s Top Stock for May 2022

7investing Lead Advisor Maxx Chatsko's top stock to buy in May 2022 serves as the linchpin of for biology-driven enterprises.

May 1, 2022

After remaining disciplined with valuations since joining the team in September 2020, 7investing Lead Advisor Maxx Chatsko believes now is a great time to gain exposure to some of the trendier — and beaten down — growth names in biotech.

His top stock to buy in May 2022 has lost three-quarters of its value in the last 12 months. However, unlike several companies that lumped into its peer group, this business is scaling quickly and enjoying the benefits of margin improvement that come along with it. Investors might take that for granted with software stocks, but it’s a much more challenging task when physical products are involved. Investors with a long-term mindset might find this to be a great time to begin or add to a position.


This stock can provide long-term growth and eventually graduate into one of the anchors of your portfolio.

Hey everyone, I’m 7investing Lead Advisor Maxx Chatsko. I cover biotechnology and renewable energy here at 7investing, where we empower you to invest in your future by giving you our seven best stock market opportunities each and every month, each backed by the domain competence of one of our lead advisors.

As many of you know, I’ve remained disciplined with valuations since joining the team in September 2020. That has largely paid off by avoiding the worst of the biotech correction and significantly outperforming biotech ETFs and hedge funds. That said, there are some pretty attractive valuations starting to emerge for some of the trendier names in biotech.

My recommendation for May 2022 is enabling some of the most important verticals in biology. The company boasts a diverse geographical footprint, a diverse revenue mix, a long list of customers, and a healthy balance sheet. It also has significant potential to address pain points in new applications not being served today.

If you want to read my full research report, then you know what to do — go to And remember, it’s never too early or too late to start investing in your future.

Join 7investing's Free Email List

Already a 7investing member? Log in here.